Hear what our attorneys are saying

04
Aug 2020

Managing Opioids in a Workers’ Compensation Case

By Rasa Fumagalli     

  Although our nation is currently focused on the COVID-19 pandemic, the opioid abuse epidemic continues to claim many lives.  According to data from the Centers for Disease Control and Prevention (CDC), almost 70% of the 67,000 deaths from drug overdoses in 2018 involved a prescription or illicit opioid.  Attempts to curb opioid abuse have
Read the full article…

Read More
29
Jul 2020

Answers by Amy

By Amy Bilton     

  Prescription drugs can make up a large part of a Medicare Set-Aside.  Since Medicare prices future prescription drugs using average wholesale price, the ultimate cost of the drugs through a pharmacy benefits manager (PBM) is often less than the average wholesale price.  The question posed is: “I would like to price out the future
Read the full article…

Read More
29
Jul 2020

Diagnostic Studies in the Allocation: Guiding Principles

By Julie A. Garrison     

  Almost every Workers’ Compensation Medicare Set-Aside (WCMSA) includes future diagnostic imaging studies, usually x-rays and MRIs.  For most work injuries, and especially orthopedic ones, diagnostic imaging studies are commonly done early in treatment.  They may be done on an emergent basis.  And it is not unusual for repeat studies to be conducted for more
Read the full article…

Read More
29
Jul 2020

Timing Your Total Payment Obligation to Claimant (TPOC) Report Under Section 111

By Rasa Fumagalli     

  Most workers’ compensation claims adjusters would agree that the best claim is a closed one.  Although the ideal settlement closes all aspects of the claim at once, this is not always feasible.  The unique circumstances of a claim may result in an indemnity only settlement with future medical rights remaining open.  The settlement terms
Read the full article…

Read More
29
Jul 2020

Uncertain Surgery Costs: A Call for Transparency in WCMSA Pricing of Allocated Surgeries

By Joseph Gregorio     

  One of the most significant cost-drivers in MSAs can be surgeries.  In addition to CMS becoming more aggressive in allocating for surgeries, we have recently seen the costs of these procedures increase as well.  This brings back not-so-fond memories from a few years ago when CMS began including urine drug screens in MSAs where
Read the full article…

Read More